Drug Shortage Report for XERESE
| Report ID | 102991 |
| Drug Identification Number | 02404044 |
| Brand name | XERESE |
| Common or Proper name | XERESE |
| Company Name | BAUSCH HEALTH, CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | ACYCLOVIR HYDROCORTISONE |
| Strength(s) | 5% 1% |
| Dosage form(s) | CREAM |
| Route of administration | TOPICAL |
| Packaging size | n/a |
| ATC code | D06BB |
| ATC description | CHEMOTHERAPEUTICS FOR TOPICAL USE |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2020-01-06 |
| Estimated end date | |
| Actual end date | 2020-03-02 |
| Shortage status | Resolved |
| Updated date | 2020-03-05 |
| Company comments | waiting QA release |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2020-03-05 | French | Compare |
| v8 | 2020-03-05 | English | Compare |
| v7 | 2020-02-14 | French | Compare |
| v6 | 2020-02-14 | English | Compare |
| v5 | 2020-02-14 | English | Compare |
| v4 | 2020-01-23 | French | Compare |
| v3 | 2020-01-23 | English | Compare |
| v2 | 2020-01-09 | French | Compare |
| v1 | 2020-01-09 | English | Compare |
Showing 1 to 9 of 9